These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3289878)

  • 41. Dipyridamole thallium scintigraphy and prognosis in coronary artery disease.
    Willerson JT
    J Am Coll Cardiol; 1990 Jan; 15(1):117-8. PubMed ID: 2295719
    [No Abstract]   [Full Text] [Related]  

  • 42. Prognostic value of thallium-201 myocardial perfusion imaging. A diagnostic tool comes of age.
    Brown KA
    Circulation; 1991 Feb; 83(2):363-81. PubMed ID: 1991361
    [No Abstract]   [Full Text] [Related]  

  • 43. Dipyridamole perfusion scintigraphy.
    Botvinick EH; Dae MW
    Semin Nucl Med; 1991 Jul; 21(3):242-65. PubMed ID: 1948114
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Myocardial perfusion imaging during pharmacologic stress testing.
    Mahmarian JJ; Verani MS
    Cardiol Clin; 1994 May; 12(2):223-45. PubMed ID: 8033174
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Persistent chest pain following oral dipyridamole for thallium 201 myocardial imaging.
    Kwai AH; Jacobson AF; McIntyre KM; Williams WH; Tow DE
    Eur J Nucl Med; 1990; 16(8-10):745-6. PubMed ID: 2384110
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Nuclear cardiology in the preoperative evaluation of the patient at risk of coronary disease; meta-analysis of the contribution of thallium dipyridamole scintigraphy].
    Delcourt E; Bourgeois D
    Rev Med Brux; 1995; 16(1):39-43. PubMed ID: 7701167
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Dipyridamole test in the diagnosis of ischemic heart disease].
    Pakulin IA; Surovov IuA; Sidorenko BA
    Kardiologiia; 1991 Feb; 31(2):99-100. PubMed ID: 2041304
    [No Abstract]   [Full Text] [Related]  

  • 48. [Clinical value of thallium-201 myocardial scintigraphy with dipyridamole performed before and after aortocoronary bypass].
    Wolff F; Demangeat JL; Chambron J; Sacrez A
    Arch Mal Coeur Vaiss; 1985 Aug; 78(8):1198-204. PubMed ID: 3935077
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Informative value of Tl-201 myocardial perfusion scintigraphy in the diagnosis of ischemic changes of the myocardium in patients with renovascular hypertension of atherosclerotic etiology].
    Matveeva AI; Dumpe AN; Muzalev IuM; Buziashvili IuI
    Kardiologiia; 1991 Apr; 31(4):19-22. PubMed ID: 2067173
    [No Abstract]   [Full Text] [Related]  

  • 50. [Tl-201 scintigraphy of the myocardium in combination with pharmacological tests in the diagnosis of ischemic heart disease].
    Tokareva EA; Sergienko VB; Sidorenko BA
    Kardiologiia; 1989 Dec; 29(12):73-7. PubMed ID: 2632930
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Coronary artery disease detected noninvasively by dipyridamole-loading 201T1 myocardial scintigraphy in elderly patients].
    Yonezawa Y; Hamashige N; Doi Y; Odawara H; Ozawa T
    J Cardiogr; 1986 Mar; 16(1):43-51. PubMed ID: 3782888
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thallium-201-dipyridamole imaging: comparison between a standard dose and a high dose of dipyridamole in the detection of coronary artery disease.
    Lalonde D; Taillefer R; Lambert R; Bisson G; Basile F; Prieto I; Benjamin C
    J Nucl Med; 1994 Aug; 35(8):1245-53. PubMed ID: 8046475
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exercise-augmented dipyridamole thallium scintigraphy in the diagnosis of coronary artery disease.
    McLean RG; Macauley RJ; Murton F; Cumming R
    Clin Nucl Med; 1994 Jul; 19(7):581-2. PubMed ID: 7924095
    [No Abstract]   [Full Text] [Related]  

  • 54. Safety of pharmacological (intravenous dipyridamole) stress for Thallium-201 perfusion imaging in patients with coronary artery disease unable to exercise.
    Zaman M; Hashmi R; Niaz K; Ahmad A; Kamal S
    J Pak Med Assoc; 1994 Oct; 44(10):237-9. PubMed ID: 7815687
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of exercise thallium-201 scintigraphy in the diagnosis and prognosis of coronary artery disease. American College of Physicians.
    Ann Intern Med; 1990 Nov; 113(9):703-4. PubMed ID: 2221650
    [No Abstract]   [Full Text] [Related]  

  • 56. [Canine myocardial images by 201thallium-Cl scintigraphy after coronary occlusion with and without reperfusion (author's transl)].
    Kaneko Y
    Kaku Igaku; 1981 Feb; 18(1):23-39. PubMed ID: 7277868
    [No Abstract]   [Full Text] [Related]  

  • 57. Dipyridamole-induced negative U waves: scintigraphic evidence of severe anterior myocardial ischemia.
    Galli M; Bosimini E; Campi A; Tavazzi L
    Am Heart J; 1989 Sep; 118(3):616-9. PubMed ID: 2773778
    [No Abstract]   [Full Text] [Related]  

  • 58. [Pharmacologic stress myocardial perfusion imaging].
    Li Y; Guan C
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2000 Dec; 17(4):457-60. PubMed ID: 11211840
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dipyridamole thallium-201 scintigraphy as a preoperative screening test.
    Lette J
    Circulation; 1992 May; 85(5):1951-2. PubMed ID: 1637406
    [No Abstract]   [Full Text] [Related]  

  • 60. Pharmacological (stress) perfusion scintigraphy: methods, advantages, and applications.
    Bateman TM; O'Keefe JH
    Am J Card Imaging; 1992 Mar; 6(1):3-13; discussion 14-5. PubMed ID: 10147612
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.